Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.88 USD | +8.27% |
|
-2.37% | -62.35% |
06-27 | GT Biopharma Says FDA Clears Investigational New Drug Application for Cancer Drug GTB-3650 | MT |
06-27 | GT Biopharma Shares Rise on FDA Clearance for Cancer-Drug Study | DJ |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration1st Jan change | Capi. | |
---|---|---|
-62.35% | 6.21M | |
+55.55% | 816B | |
+40.05% | 634B | |
-6.83% | 351B | |
+17.15% | 323B | |
+7.09% | 293B | |
+14.09% | 238B | |
+1.39% | 222B | |
+13.66% | 218B | |
+7.87% | 167B |
- Stock Market
- Equities
- GTBP Stock
- News GT Biopharma, Inc.
- GT Biopharma CEO Anthony Cataldo, CFO Michael Handelman Step Down to Pursue Other Interests; Shares Decline